Streptococcus pneumoniae vaccine - Serum Institute of India
Alternative Names: Streptococcus pneumoniae Whole Cell Vaccine; wSp vaccineLatest Information Update: 19 Oct 2025
At a glance
- Originator Serum Institute of India
- Class Conjugate vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Pneumococcal infections
Most Recent Events
- 29 Sep 2025 Serum Life Science Europe GmbH plans phase II wSp005 trial in Otitis media (In Infants) in US (IM, Injection) (NCT07216430)
- 29 Aug 2025 Serum Life Science Europe completes a phase I trial in Pneumococcal infections (Prevention) in USA (IM) (NCT07059182)
- 11 Jun 2025 Phase-I clinical trials in Pneumococcal infections (Prevention) in USA (IM) (NCT07059182)